LLY vs NVS

Eli Lilly and Company against Novartis AG — live side-by-side technical comparison.

Prices as of 2026-11-11T14:35:26+00:00 UTC · updates daily

Who leads right now

LLY leads 6 of the 6 windows we measure — over 1 month LLY is +21.5% and NVS +10.8%; over year to date LLY is +33.3% and NVS +15.6%. The LLY/NVS price ratio stands at 8.8991, above its 50-day average of 8.238, and above the 200-day average of 7.2564. A ratio above its own average means LLY is gaining on NVS; on this reading the recent edge belongs to LLY.

LLY/NVS over the last year

LLY/NVS price ratio · dashed: its 50- and 200-day lines · ratio above its 50-day line = LLY gaining on NVS
5.7776.8577.9389.019
Both rebased to 100 on 2025-11-11
100104.9126.1144.7LLYNVS
Ask
Compare LLY and NVS: which has been stronger over the last year, and where does each stand against its 200-day average? Ask the analyst about this pair →

Performance side by side

LLYNVS
Price$1418.60 $159.41
1 day -1.0%lead -2.4%
5 days +1.6%lead -3.4%
1 month +21.5%lead +10.8%
6 months +51.0%lead +9.8%
Year to date +33.3%lead +15.6%
1 year +43.5%lead +22.2%
2 years — +50.9%
52-week position 94% of range 77% of range
52-week range $850.51–$1453.00 $123.24–$170.46
vs 50-day average above $1229.68 above $149.21
vs 200-day average above $1105.12 above $152.44
RSI (14) 67 56
Market cap$1.28T—
Analyst target $1453.40 (+1.5%) —
Analysts29—
ConsensusBuy—
Next earnings Oct 29, 2026 Oct 27, 2026

Where each one stands

LLY — Eli Lilly and Company

LLY trades at $1,418.60, above its 50-day average of $1,229.68, and above the 200-day at $1,105.12. It sits at 94% of its 52-week range ($850.51–$1,453.00); 14-day RSI is 67, in neutral territory; an average session moves it about 3.6%. For levels, the first level overhead is $1,432.29 (1.0% away) and the first support below is $1,400.00 (1.3% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

NVS — Novartis AG

NVS trades at $159.41, above its 50-day average of $149.21, and above the 200-day at $152.44. It sits at 77% of its 52-week range ($123.24–$170.46); 14-day RSI is 56, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $160.57 (0.7% away) and the first support below is $156.17 (2.0% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.

Which one moves harder

LLY is the more volatile of the two — an average session moves it 3.6% against 2.4% for NVS, so an identical position size carries roughly 1.5× the daily risk.

What would change the picture

The comparison turns on those levels: LLY clearing $1,432.29 or losing $1,400.00; NVS clearing $160.57 or losing $156.17. Until one of them gives way, the relative reading above stands.

Questions people ask about LLY vs NVS

Which is performing better right now, LLY or NVS?
Over the past month LLY is +21.5% and NVS is +10.8%, so LLY is ahead on that window. Year to date the figures are +33.3% for LLY and +15.6% for NVS.
Which has done better over the last year, LLY or NVS?
Over the last year LLY is +43.5% and NVS is +22.2%, so LLY is ahead on that window.
Is LLY or NVS more volatile?
LLY is the more volatile of the two — an average session moves it 3.6% against 2.4% for NVS, so an identical position size carries roughly 1.5× the daily risk.
What are the key levels for LLY and NVS?
LLY: resistance $1,432.29, support $1,400.00; NVS: resistance $160.57, support $156.17. Levels come from recent swing zones and round numbers, recomputed daily.
When do LLY and NVS report next?
LLY: Oct 29, 2026. NVS: Oct 27, 2026. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the LLY/NVS ratio mean?
It is simply LLY's price divided by NVS's — 8.8991 today. When the ratio rises, LLY is outperforming; when it falls, NVS is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

LLY →
Eli Lilly and Company
Full technical brief: trend, levels, chart, news
NVS →
Novartis AG
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs MerckLLY vs UNHAZN vs LLYLLY vs TMOAMGN vs LLYGILD vs LLY